Pharmaceutical research, democracy and conspiracy : international clinical trials in local medical institutions / Edison Bicudo, King's College, London, UK.
Series: Gower applied researchPublisher: Farnham, Surrey, England : Gower, [2014]Copyright date: @2014Description: xvi, 175 pages ; 25 cmContent type:- text
- unmediated
- volume
- 9781472423573 (hardback : alk. paper)
- 1472423577 (hardback : alk. paper)
- 1472423593 (electronic bk.)
- 1472423585 (electronic bk.)
- Drugs -- Testing -- Government policy
- Clinical trials -- Moral and ethical aspects
- Pharmaceutical industry -- Moral and ethical aspects
- Clinical trials -- Moral and ethical aspects
- Drugs -- Testing -- Government policy
- Pharmaceutical industry -- Moral and ethical aspects
- Clinical Trials as Topic -- ethics
- Drug Industry -- ethics
| Item type | Current library | Home library | Collection | Call number | Materials specified | Copy number | Status | Date due | Barcode | |
|---|---|---|---|---|---|---|---|---|---|---|
| AM | PERPUSTAKAAN DR ABDUL LATIFF | PERPUSTAKAAN DR ABDUL LATIFF KOLEKSI AM-P. DR ABDUL LATIFF | - | QV21.B583p 2014 9 (Browse shelf(Opens below)) | 1 | Available | 00002123775 |
Includes bibliographical references (pages 165-171) and index.
Machine generated contents note: 0.1.What is a Global Clinical Trial? -- 0.2.What is a CRO? -- 0.3.Multicentre Trials and Social Actions -- 0.4.Aims -- 0.5.Methods, Fieldwork, and Limitations -- 0.6.The Structure of the Book -- 0.7.What is Schrodinger's Cat? -- pt. ONE GLOBAL TRIALS IN MEDICAL INSTITUTIONS -- ch. 1 Infrastructure: The Indirect Privatization of Hospitals -- 1.1.National Regulatory Renewals -- 1.2.The Global Space of Multinational CROs -- 1.3.What are Feasibility Studies? -- 1.4.Criteria to Include or Exclude Sites -- 1.5.What is'n'? -- 1.6.Multicentre Trials and'Systems of Objects' -- 1.7.Multicentre Trials and'Systems of Actions' -- 1.8.Recruitment Partnerships -- 1.9.The Indirect Privatization of Hospitals -- ch. 2 Payments: Global Trials and Local Agreements -- 2.1.Institutional Mechanisms -- 2.2.What is a Research Contract? -- 2.3.What is a Study's Budget? -- 2.4.Hybrid Work -- 2.5.The Dark Side of Research Contracts --
Contents note continued: 2.6.Global Trials and Local Agreements -- ch. 3 Care: The Global Need for Global Trials -- 3.1.Who are Key Opinion Leaders? -- 3.2.What is a Therapeutic Trial? -- 3.3.Clinical Trials and Medical Decisions -- 3.4.Criteria to Include or Exclude People -- 3.5.Clinical Agreements -- 3.6.Therapy and Care -- 3.7.Global Trials and'Disposable Income' -- 3.8.The Global Need for Global Trials -- pt. TWO GLOBAL TRIALS IN THE GEOGRAPHICAL SPACE -- ch. 4 Communication: The Collective Design of Clinical Protocols -- 4.1.Research Sites and'Communicational Densities' -- 4.2.Clinical Trials in Urban Contexts -- 4.3.The Medical Community -- 4.4.Where do Research Subjects Really Come From? -- 4.5.Global Trials Embedded in Local Contexts -- 4.6.What is a Protocol's Amendment? -- 4.7.The Collective Design of Clinical Protocols -- ch. 5 Globalization: Clinical Trials and International Hierarchies -- 5.1.What are Rescue Countries? --
Contents note continued: 5.2.Criteria to Include or Exclude Countries -- 5.3.What is Competitive Recruitment? -- 5.4.Clinical Trials and International Hierarchies -- ch. 6 Hope: The Symbolic Dimension of Global Trials -- 6.1.The'Symbolic Efficacy' of Medicines -- 6.2.The Limits of Medicine -- 6.3.How Trustable are Clinical Trials? -- 6.4.Global Trials for Hopeful Patients -- 6.5.Global Trials for Hopeless Hospitals -- 6.6.The Symbolic Dimension of Global Trials -- Conclusion -- Intermediary Groups and Sociology -- Towards a General Theory of Communicative Action -- Global Trials and Institutionalization.
There are no comments on this title.
